Epigral Ltd. (EPIGRAL) — Capital Reinvestment Ratio
Epigral Ltd. (EPIGRAL) has a Capital Reinvestment Ratio of 0.44x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs4.41 Billion) in capital expenditures (Rs1.95 Billion). See EPIGRAL equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Epigral Ltd. Capital Reinvestment Ratio (2015–2025)
This chart tracks Epigral Ltd.'s Capital Reinvestment Ratio across 11 annual periods. Check Epigral Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Epigral Ltd. (2015–2025)
Year-by-year Capital Reinvestment Ratio for Epigral Ltd. from 2015 to 2025. For live market cap and broader valuation context, see market cap of Epigral Ltd..
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | Rs4.41 Billion | Rs1.95 Billion | ▼ -55.9% |
| 2024 | 1.00x | Rs3.98 Billion | Rs3.98 Billion | ▲ +50.7% |
| 2023 | 0.67x | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.6% |
| 2022 | 1.61x | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.3% |
| 2021 | 0.86x | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs1.12 Billion | Rs34.48 Million | — |